Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

866427

registered interest
date	19/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care what assessment he has made of the effect of charging VAT on the affordability and accessibility of medicines.
tabling member constituency	Brentford and Isleworth
tabling member printed	Ruth Cadbury
uin	904465
answer	answer is ministerial correction date of answer 20/03/2018 answer text <p>Value Added Tax (VAT) paid by the National Health Service on the purchase of medicines is fully incorporated within the funding allocated to the NHS each year.</p><p>As is the case with many other goods and services, VAT is chargeable at 20% to members of the public when purchasing over the counter and non-prescription medicines.</p><p> </p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/03/2018 15:37:51 answering member 4067 label Biography information for Steve Brine
tabling member	4389 label Biography information for Ruth Cadbury

864434

registered interest
date	15/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Inflammatory Bowel Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that GPs receive a copy of Crohn's & Colitis UK's latest Inflammatory Bowel Disease toolkit to improve (a) awareness, (b) early diagnosis and (b) treatment plans for that condition.
tabling member constituency	Great Grimsby
tabling member printed	Melanie Onn
uin	132917
answer	answer is ministerial correction date of answer 20/03/2018 answer text <p>In August 2017, Crohn’s and Colitis UK in partnership with the Royal College of General Practitioners (RCGP) launched a new Inflammatory Bowel Disease (IBD) toolkit: an online resource for general practitioners (GPs) and healthcare professionals designed to improve understanding of Crohn’s Disease and Ulcerative Colitis, collectively known as IBD. The Toolkit was developed as part of a 12 month project on IBD, and includes a range of resources for GPs to improve detection of inflammatory bowel disease and to support primary care clinicians in treating, managing and referring patients with the condition.</p><p> </p><p>The Toolkit was promoted at events across the United Kingdom and an IBD Twitter chat with an expert panel was held in February 2018. The Toolkit, regional events and Twitter session were all promoted to GPs via the RCGP website and newsletter and more widely by Crohn’s and Colitis UK. The Toolkit can be found at the following link:</p><p> </p><p><a href="http://www.rcgp.org.uk/clinical-and-research/resources/toolkits/inflammatory-bowel-disease-toolkit.aspx" target="_blank">www.rcgp.org.uk/clinical-and-research/resources/toolkits/inflammatory-bowel-disease-toolkit.aspx</a></p><p> </p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/03/2018 16:31:16 answering member 4067 label Biography information for Steve Brine
tabling member	4464 label Biography information for Melanie Onn

862028

registered interest
date	14/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to reduce the time between EU marketing authorisation and NICE appraisal of treatments for serious and progressive conditions and improve the timeliness of making such treatments available to patients.
tabling member constituency	Chesham and Amersham
tabling member printed	Dame Cheryl Gillan
uin	132447
answer	answer is ministerial correction date of answer 19/03/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) routinely aims to publish draft technology appraisal guidance on new non-cancer drugs within six months of licensing, and to publish draft guidance on new cancer drugs before licensing.</p><p> </p><p>National Health Service commissioners are legally required to make funding available for treatments recommended in NICE technology appraisal guidance within three months of the publication of guidance. In April 2017, NICE introduced a new fast track appraisal process that is designed to bring forward patient access to drugs where the company can demonstrate clear cost-effectiveness by around five months compared with the standard timescales.</p><p> </p><p>The Government has also published the response to the Accelerated Access Review which includes the introduction of a new Accelerated Access Pathway and £86 million of funding to support medical innovations get to patients faster. This will streamline regulatory and market access decisions, getting breakthrough products that we believe will be truly transformative to patients more quickly, and will be operational from April 2018. All products including medical technologies, devices and diagnostics will be eligible for selection.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/03/2018 14:29:55 answering member 4067 label Biography information for Steve Brine
tabling member	18 label Biography information for Dame Cheryl Gillan

862029

registered interest
date	14/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what timeline is for NHS England to complete commercial negotiations with pharmaceutical companies after a treatment has met the NICE budget impact test; and what steps he is taking to ensure that those treatments are available to patients in a timely manner.
tabling member constituency	Chesham and Amersham
tabling member printed	Dame Cheryl Gillan
uin	132448
answer	answer is ministerial correction date of answer 19/03/2018 answer text <p>The timescales for the commercial negotiations for products that trigger the budget impact test are set out in the ‘Procedure for varying the funding requirement to take account of net budget impact’ which is published at:</p><p> </p><p><a href="https://www.nice.org.uk/Media/Default/About/what-we-do/NICE-guidance/NICE-technology-appraisals/TA-HST-procedure-varying-the-funding-direction.pdf" target="_blank">https://www.nice.org.uk/Media/Default/About/what-we-do/NICE-guidance/NICE-technology-appraisals/TA-HST-procedure-varying-the-funding-direction.pdf</a></p><p> </p><p>The process has been designed to ensure that, wherever possible, the commercial negotiation takes place in parallel with the technology appraisal and does not affect patient access.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/03/2018 14:27:28 answering member 4067 label Biography information for Steve Brine
tabling member	18 label Biography information for Dame Cheryl Gillan

862149

registered interest
date	14/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Halton Clinical Commissioning Group
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 5 March 2018 to Question 130487, on Clinical Commissioning Groups: Halton, for what reasons two successive Chief Officers have been appointed on an interim basis; and when the timetable for the appointment of a permanent Chief Officer will be decided.
tabling member constituency	Halton
tabling member printed	Derek Twigg
uin	132568
answer	answer is ministerial correction date of answer 19/03/2018 answer text <p>Andrew Davies was appointed as Chief Clinical Officer with an effective start date of 1st February 2018. This appointment has been made as a result of the interim Chief Officer’s move to an Sustainability and Transformation Partnership (STP) role.</p><p> </p><p>Following the departure of Halton Clinical Commissioning Group’s Accountable Officer (AO) in May 2017, interim arrangements were quickly put in place to ensure continuity.</p><p> </p><p>This was an internal appointment. The interim AO has subsequently been successful in their application for a short-term, 12-month secondment with the Cheshire and Merseyside STP. As a result, further interim arrangements were needed to cover this period.</p><p> </p><p>NHS England is content with the current arrangements and will keep them under review on a quarterly basis.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/03/2018 14:25:58 answering member 4067 label Biography information for Steve Brine
tabling member	429 label Biography information for Derek Twigg

862154

registered interest
date	14/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Halton Clinical Commissioning Group
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what proportion of his time the interim Chief Officer for Halton Clinical Commissioning Group spends in (a) Halton and (b) Warrington.
tabling member constituency	Halton
tabling member printed	Derek Twigg
uin	132573
answer	answer is ministerial correction date of answer 19/03/2018 answer text <p>NHS England has advised that the role is a joint appointment and Dr Andrew Davies spends 50% of his time at each clinical commissioning group (CCG). Dr Davies works additional hours to ensure that he fulfils all his responsibilities and attends both CCGs’ governing bodies, committees and other meetings as required.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/03/2018 14:33:34 answering member 4067 label Biography information for Steve Brine
tabling member	429 label Biography information for Derek Twigg

862159

registered interest
date	14/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Clinical Commissioning Groups: Merseyside and Cheshire
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many Clinical Commissioning Groups in (a) Cheshire and (b) Merseyside do not have a permanent Chief Officer.
tabling member constituency	Halton
tabling member printed	Derek Twigg
uin	132578
answer	answer is ministerial correction date of answer 19/03/2018 answer text <p>NHS England advises that there are two others. However, interviews have been held recently and, subject to all necessary approvals, there is expected to be permanent appointment to one of the posts in the near future.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/03/2018 14:34:38 answering member 4067 label Biography information for Steve Brine
tabling member	429 label Biography information for Derek Twigg

862162

registered interest
date	14/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Air Pollution: Death
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate the Government has made of the number of deaths per year caused by air pollution in each of the last five years.
tabling member constituency	Hornsey and Wood Green
tabling member printed	Catherine West
uin	132581
answer	answer is ministerial correction date of answer 19/03/2018 answer text <p>The Public Health Outcomes Framework (PHOF) for England includes an indicator for air pollution expressed as the fraction of adult mortality attributable to long-term exposure to human-made particulate air pollution. The most recent published estimates available are for 2015. For England, estimates within the last five years are: 2013: 5.3%; 2014: 5.1%; 2015: 4.7%.</p><p> </p><p>Figures for 2016 are due to be published with the next release of updated PHOF data in May 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/03/2018 14:30:55 answering member 4067 label Biography information for Steve Brine
tabling member	4523 label Biography information for Catherine West

862297

registered interest
date	14/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Public Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to implement Public Health England's Health in all policies, published in October 2016.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	132716
answer	answer is ministerial correction date of answer 19/03/2018 answer text <p>Health in All Policies (HiAP) is a collaborative approach to improving the health of all people by incorporating health considerations into decision making across sectors, policy and service areas, and addressing the wider determinants of health.</p><p> </p><p>Public Health England worked with the Association of Directors of Public Health and the Local Government Association to develop masterclasses to understand how to support Directors of Public Health and local government to adopt health and health equity in all policies at a local level. The HiAP approach has been adopted in various forms by Swindon, Medway, Bristol and Blackburn Councils.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/03/2018 14:32:25 answering member 4067 label Biography information for Steve Brine
tabling member	4036 label Biography information for Luciana Berger

861115

registered interest
date	13/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antimicrobials: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when his Department plans to publish a new five year AMR Strategy, and whether that strategy will include best practice on infection prevention and control, including hand hygiene compliance.
tabling member constituency	Thirsk and Malton
tabling member printed	Kevin Hollinrake
uin	132264
answer	answer is ministerial correction date of answer 16/03/2018 answer text <p>The current five year United Kingdom Antimicrobial Resistance (AMR) strategy was published at the end of 2013. Work is underway to consider the priorities and focus for a refreshed strategy and national action plan for publication at the end of 2018. The refreshed strategy will continue to focus on preventing infections as one of its key pillars.</p><p> </p><p>The current AMR programme has an ambition to halve healthcare associated Gram–negative blood stream infections by 2020/2021. NHS Improvement leads this work and has included hand hygiene in its work programme for 2018/19 in support of the ambition. As part of our work on the refreshed strategy, we will consider how to make best use of evidence-based and cost-effective technology.</p><p> </p><p>We are working with our partners across the health and social care system, including the Care Quality Commission, to ensure that consideration of best practice in hand hygiene policies remains a focus of inspections in acute trusts.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 132266 question first answered 16/03/2018 11:42:43 answering member 4067 label Biography information for Steve Brine
tabling member	4474 label Biography information for Kevin Hollinrake